Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
Luxfer Holdings
LXFR
$460M
| $3.15M | ﹤0.01% |
174,349
-19,810
| -10% | -$309K |
|
4477
Schwab 1000 Index ETF
SCHK
$5.76B
| $3.14M | ﹤0.01% |
87,022
-504
| -0.6% | -$17.6K |
|
|
RC
4478
Ready Capital
RC
$261M
| $3.14M | ﹤0.01% |
1,792,938
+93,976
| +6% | +$165K |
|
|
AVBC
4479
Avidia Bancorp
AVBC
$412M
| $3.13M | ﹤0.01% |
149,088
+25,163
| +20% | +$502K |
|
4480
Oculis Holding
OCS
$550M
| $3.12M | ﹤0.01% |
225,083
+158,846
| +240% | +$3.61M |
|
|
HAWK
4481
HawkEye 360 Inc
HAWK
$1.58B
| $3.12M | ﹤0.01% |
+154,357
| New | +$4.26M |
|
|
TWN
4482
Taiwan Fund
TWN
$564M
| $3.12M | ﹤0.01% |
32,403
+12,268
| +61% | +$1.1M |
|
|
ARDT
4483
Ardent Health
ARDT
$1.51B
| $3.11M | ﹤0.01% |
315,960
+23,929
| +8% | +$227K |
|
4484
Cytek Biosciences
CTKB
$641M
| $3.11M | ﹤0.01% |
701,792
-1,017,083
| -59% | -$4.34M |
|
4485
Traeger
COOK
$136M
| $3.11M | ﹤0.01% |
39,430
+19,560
| +98% | +$1.02M |
|
4486
ProFrac Holding
ACDC
$881M
| $3.11M | ﹤0.01% |
534,734
-6,755
| -1% | -$45.5K |
|
4487
Invesco KBW Property & Casualty Insurance ETF
KBWP
$281M
| $3.11M | ﹤0.01% |
24,504
+3,566
| +17% | +$429K |
|
|
MCI
4488
Barings Corporate Investors
MCI
$389M
| $3.11M | ﹤0.01% |
176,852
-687
| -0.4% | -$12K |
|
4489
Medifast
MED
$134M
| $3.1M | ﹤0.01% |
292,508
-32,804
| -10% | -$378K |
|
4490
Invesco MSCI Sustainable Future ETF
ERTH
$126M
| $3.1M | ﹤0.01% |
65,593
-2,769
| -4% | -$136K |
|
4491
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
| $3.1M | ﹤0.01% |
57,640
-17,119
| -23% | -$870K |
|
4492
ALPS Strategic Income Fund
RIGS
$61.9M
| $3.1M | ﹤0.01% |
135,986
-24,968
| -16% | -$570K |
|
4493
VanEck Environmental Services ETF
EVX
$97.3M
| $3.1M | ﹤0.01% |
75,143
+683
| +0.9% | +$27.1K |
|
|
DMRA
4494
Damora Therapeutics
DMRA
$1.51B
| $3.1M | ﹤0.01% |
119,027
+22,250
| +23% | +$539K |
|
|
EDN
4495
Edenor
EDN
$1.04B
| $3.09M | ﹤0.01% |
123,695
-35,745
| -22% | -$939K |
|
4496
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$899M
| $3.08M | ﹤0.01% |
70,412
+2,746
| +4% | +$132K |
|
|
TWFG
4497
TWFG Inc
TWFG
$348M
| $3.08M | ﹤0.01% |
127,879
+16,353
| +15% | +$321K |
|
|
GAU
4498
Galiano Gold
GAU
$531M
| $3.07M | ﹤0.01% |
1,641,182
-2,143,220
| -57% | -$4.97M |
|
4499
2x Long VIX Futures ETF
UVIX
$186M
| $3.07M | ﹤0.01% |
49,630
+29,887
| +151% | +$2.97M |
|
|
HELP
4500
Cybin Inc
HELP
$984M
| $3.05M | ﹤0.01% |
461,886
-563,432
| -55% | -$2.82M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.